Related Experiment Video
Updated: Nov 26, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 sponge
Di Wu1, Anliang Xia2,3, Tianlong Fan1
1Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, P.R. China.
Abstract:
Circular RNAs (circRNAs) are a class of non-coding RNAs broadly expressed in cells of various species. However, the contributions and molecular mechanisms of circRNAs to hepatocellular carcinoma (HCC) remain largely unknown. In the present study, we compared the expression of circRNAs between five paired HCC and adjacent noncancerous liver (ANL) tissues by using RNA-sequencing (RNA-seq). circRASGRF2 (a circRNA located on chromosome 5 and derived from RASGRF2, hsa_circ_0073181) was identified and validated by quantitative reverse transcriptase PCR. The role of circRASGRF2 in HCC progression was assessed both in vitro and in vivo. Mechanistically, RNA immunoprecipitation and luciferase reporter assays were performed to confirm the interaction between circRASGRF2 and miR-1224 in HCC. circRASGRF2 was found to be significantly upregulated in HCC tissues and HCC cell lines compared with paired ANL tissues and normal cells. Our in vivo and in vitro data indicated that knockdown of circRASGRF2 inhibits the proliferation and migration of HCC cells. Mechanistically, we found that circRASGRF2 could promote the expression of focal adhesion kinase (FAK) by sponging miR-1224. Our data showed that circRASGRF2 is a central component linking circRNAs to progression of HCC, making it a potential therapeutic target.
Insights
Circular RNAs (circRNAs) are implicated in hepatocellular carcinoma (HCC). This study identifies circRASGRF2 as upregulated in HCC, inhibiting proliferation and migration by sponging miR-1224 and promoting FAK expression, suggesting it as a therapeutic target.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) are non-coding RNAs with largely unknown roles in hepatocellular carcinoma (HCC).
- Understanding circRNA mechanisms in HCC is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the role and molecular mechanisms of circRNAs in hepatocellular carcinoma (HCC) progression.
- To identify specific circRNAs involved in HCC and assess their therapeutic potential.
Main Methods:
- RNA-sequencing (RNA-seq) to compare circRNA expression in HCC and adjacent noncancerous liver (ANL) tissues.
- Quantitative reverse transcriptase PCR for validation of circRASGRF2.
- In vitro and in vivo assays to assess circRASGRF2 function.
- RNA immunoprecipitation and luciferase reporter assays to elucidate molecular mechanisms.
Main Results:
- circRASGRF2 (hsa_circ_0073181) was identified and significantly upregulated in HCC tissues and cell lines.
- Knockdown of circRASGRF2 inhibited HCC cell proliferation and migration in vitro and in vivo.
- circRASGRF2 promotes focal adhesion kinase (FAK) expression by sponging miR-1224.
Conclusions:
- circRASGRF2 plays a critical role in promoting HCC progression.
- circRASGRF2 acts as a molecular sponge for miR-1224, upregulating FAK expression.
- circRASGRF2 represents a potential therapeutic target for hepatocellular carcinoma.
Related Concept Videos
The Ras Gene
Ras is a...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

